Last update 08 May 2025

KN-510

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
SLC25A20
Action
blockers
Mechanism
SLC25A20 blockers(solute carrier family 25 member 20 blockers)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Advanced Malignant Solid NeoplasmPancreatic Cancer
Inactive Indication-
Originator Organization
New Cancer Cure-Bio Co.,Ltd.
Active Organization
New Cancer Cure-Bio Co.,Ltd.National Cancer Center KoreaNational Cancer Center Korea
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with KN-510
NCT06012708
/ CompletedPhase 1
An Open-label, Dose-escalation and Dose-finding, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 as Combination Therapy in Patients With Advanced Solid Tumors
100 Clinical Results associated with KN-510
Login to view more data
100 Translational Medicine associated with KN-510
Login to view more data
100 Patents (Medical) associated with KN-510
Login to view more data
100 Deals associated with KN-510
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
United States
New Cancer Cure-Bio Co.,Ltd.
11 Sep 2023
Pancreatic CancerPreclinical
South Korea
National Cancer Center KoreaNational Cancer Center Korea
28 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free